Prevalence of metabolic syndrome and its components in Chinese women with premature ovarian insufficiency

References

• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1–5. doi: 10.1161/CIRCULATIONAHA.109.192644.
   PubMed Web of Science ®Google Scholar
• Chon SJ, Umair Z, Yoon MS. Premature ovarian insufficiency: past, present, and future. Front Cell Dev Biol. 2021;9:672890. doi: 10.3389/fcell.2021.672890.
   PubMed Web of Science ®Google Scholar
• Podfigurna A, Męczekalski B. Cardiovascular health in patients with premature ovarian insufficiency. Management of long-term consequences. Prz Menopauzalny. 2018;17(3):109–111. doi: 10.5114/pm.2018.78551.
   PubMedGoogle Scholar
• Podfigurna A, Stellmach A, Szeliga A, et al. Metabolic profile of patients with premature ovarian insufficiency. J Clin Med. 2018;7(10):374. doi: 10.3390/jcm7100374.
   PubMed Web of Science ®Google Scholar
• Mumusoglu S, Yildiz O. Metabolic syndrome during menopause. Curr Vasc Pharmacol. 2019;17(6):595–603. doi: 10.2174/1570161116666180904094149.
   PubMed Web of Science ®Google Scholar
• Pu D, Tan R, Yu Q, et al. Metabolic syndrome in menopause and associated factors: a meta-analysis. Climacteric. 2017;20(6):583–591. doi: 10.1080/13697137.2017.1386649.
   PubMed Web of Science ®Google Scholar
• Ruan X, Jin J, Hua L, et al. The prevalence of metabolic syndrome in Chinese postmenopausal women and the optimum body composition indices to predict it. Menopause. 2010;17(3):566–570. doi: 10.1097/gme.0b013e3181c8f4e1.
   PubMed Web of Science ®Google Scholar
• Webber L, Davies M, Anderson R, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926–937.
   PubMed Web of Science ®Google Scholar
• Nappi RE, Chedraui P, Lambrinoudaki I, et al. Menopause: a cardiometabolic transition.Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022;10(6):442–456. doi: 10.1016/S2213-8587(22)00076-6.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Guo X, Sun G, et al. Exploring the link between number of years since menopause and metabolic syndrome among women in rural China: a cross-sectional observational study. Gynecol Endocrinol. 2018;34(8):670–674. doi: 10.1080/09513590.2018.1441400.
   PubMed Web of Science ®Google Scholar
• Stevenson JC, Collins P, Hamoda H, et al. Cardiometabolic health in premature ovarian insufficiency. Climacteric. 2021;24(5):474–480. doi: 10.1080/13697137.2021.1910232.
   PubMed Web of Science ®Google Scholar
• Ishizuka B. Current understanding of the etiology, symptomatology, and treatment options in premature ovarian insufficiency (POI). Front Endocrinol (Lausanne). 2021;12:626924. doi: 10.3389/fendo.2021.626924.
   PubMed Web of Science ®Google Scholar
• Jeong HG, Park H. Metabolic disorders in menopause. Metabolites. 2022;12(10):954. doi: 10.3390/metabo12100954.
   PubMed Web of Science ®Google Scholar
• Bompoula MS, Valsamakis G, Neofytou S, et al. Demographic, clinical and hormonal characteristics of patients with premature ovarian ­insufficiency and those of early menopause: data from two tertiary premature ovarian insufficiency centers in Greece. Gynecol Endocrinol. 2020;36(8):693–697. doi: 10.1080/09513590.2020.1739266.
   PubMed Web of Science ®Google Scholar
• Fahed G, Aoun L, Zerdan MB, et al. Metabolic syndrome: updates on pathophysiology and management in 2021. Int J Mol Sci. 2022;23(2):786. doi: 10.3390/ijms23020786.
   PubMed Web of Science ®Google Scholar
• Podfigurna-Stopa A, Czyzyk A, Grymowicz M, et al. Premature ovarian insufficiency: the context of long-term effects. J Endocrinol Invest. 2016;39(9):983–990. doi: 10.1007/s40618-016-0467-z.
   PubMed Web of Science ®Google Scholar
• Zhu D, Chung HF, Dobson AJ, et al. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data. Lancet Public Health. 2019;4(11):e553–e564. doi: 10.1016/S2468-2667(19)30155-0.
   PubMed Web of Science ®Google Scholar
• Gunning MN, Meun C, van Rijn BB, et al. The cardiovascular risk profile of Middle age women previously diagnosed with premature ovarian insufficiency: a case-control study. PLoS One. 2020;15(3):e0229576. doi: 10.1371/journal.pone.0229576.
   PubMed Web of Science ®Google Scholar
• Ates S, Yesil G, Sevket O, et al. Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls. Maturitas. 2014;79(3):306–310. doi: 10.1016/j.maturitas.2014.07.008.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Bitzer J, Cano A, et al. Menopause symptom management in women with dyslipidemias: an EMAS clinical guide. Maturitas. 2020;135:82–88. doi: 10.1016/j.maturitas.2020.03.007.
   PubMed Web of Science ®Google Scholar
• Wang Z, Fang L, Wu Z, et al. A meta-analysis of serum lipid profiles in premature ovarian insufficiency. Reprod Biomed Online. 2022;44(3):539–547. doi: 10.1016/j.rbmo.2021.09.018.
   PubMed Web of Science ®Google Scholar
• Huang Y, Lv Y, Qi T, et al. Metabolic profile of women with premature ovarian insufficiency compared with that of age-matched healthy controls. Maturitas. 2021;148:33–39. doi: 10.1016/j.maturitas.2021.04.003.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Patroklos Theocharis P, Lallas K, et al. Early menopause is associated with increased risk of arterial hypertension: a systematic review and meta-analysis. Maturitas. 2020;135:74–79. doi: 10.1016/j.maturitas.2020.03.006.
   PubMed Web of Science ®Google Scholar
• Gunning MN, Meun C, van Rijn BB, et al. Coronary artery calcification in middle-aged women with premature ovarian insufficiency. Clin Endocrinol (Oxf). 2019;91(2):314–322. doi: 10.1111/cen.14003.
   PubMed Web of Science ®Google Scholar
• Cai W, Luo X, Wu W, et al. Metabolic differences in women with premature ovarian insufficiency: a systematic review and meta-analysis. J Ovarian Res. 2022;15(1):109. doi: 10.1186/s13048-022-01041-w.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Christou K, Artzouchaltzi AM, et al. Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Endocrinol. 2019;180(1):41–50. doi: 10.1530/EJE-18-0602.
   PubMed Web of Science ®Google Scholar
• Kunicki M, Rudnicka E, Skórska J, et al. Insulin resistance indexes in women with premature ovarian insufficiency-a pilot study. Ginekol Pol. 2018;89(7):364–369. doi: 10.5603/GP.a2018.0062.
   PubMed Web of Science ®Google Scholar
• Sayan S, Pekin T, Yıldızhan B. Relationship between vasomotor symptoms and metabolic syndrome in postmenopausal women. J Int Med Res. 2018;46(10):4157–4166. doi: 10.1177/0300060518790709.
   PubMed Web of Science ®Google Scholar
• Lobo RA. What drives metabolic syndrome after menopause, and can we do anything about it? Menopause. 2020;27(9):972–973. doi: 10.1097/GME.0000000000001610.
   PubMed Web of Science ®Google Scholar
• Panay N, Anderson RA, Nappi RE, et al. Premature ovarian insufficiency: an International Menopause Society White Paper. Climacteric. 2020;23(5):426–446. doi: 10.1080/13697137.2020.1804547.
   PubMed Web of Science ®Google Scholar